Apoptosis of lymphocytes in atopic dermatitis in treatment with transfer factor;Apoptosis de linfocitos en dermatitis atópica en el tratamiento con factor de transferencia

Revista Alergia Mexico

Volumn 50, Issue 1, 2003, Pages 3-7

  Ángeles, Jesús García ^a   Sandoval, Graciela Flores ^a   Solano, Modesto Orea ^a   Serrano, Ernestina ^a   Parra, Sergio Estrada ^a  

^a NONE

Author keywords

Apoptosis; Atopic dermatitis; Lymphocytes; Transfer factor

Indexed keywords

FAS ANTIGEN; TRANSFER FACTOR; LIPOCORTIN 5;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; LYMPHOCYTE; NICK END LABELING; TREATMENT OUTCOME; FEMALE; HAY FEVER; HOSPITALIZATION; MALE; NEUTROPHIL; PATHOLOGY; PRESCHOOL CHILD; T LYMPHOCYTE;

ADOLESCENT; ADULT; ANNEXIN A5; ANTIGENS, CD95; APOPTOSIS; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; FEMALE; HUMANS; IN SITU NICK-END LABELING; MALE; NEUTROPHILS; RHINITIS, ALLERGIC, SEASONAL; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES; TRANSFER FACTOR; TREATMENT OUTCOME;

EID: 29944441559     PISSN: 00025151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Akdis C. Immune regulation in atopic dermatitis. Curr Op Immunol 2000:12(64):641-9.
2. Orteu CH, et al. The inhibition of cutaneous T cell apoptosis may prevent resolution of inflammation in atopic eczema. Clin Exp Immunol 2000;122(2):150-6.
3. Leung D. Pathogenesis of atopic dermatitis. J Allergy Clin Immunol 1999;104:S99-S108.
4. Walker C. Atopic dermatitis: correlation of peripheral blood T cell activation, eosinophilia and serum factors with clinical severity. Clin Exp Allergy 1993;23:145-53.
5. Salmon M. Inhibition of T cell apoptosis: a mechanism for the persistence of chronic inflammation. Immunologist 1997;5:87-92.
6. Curtis A. Apoptosis and cutaneous biology. J Am Acad Dermatol 1997;36(6):885-96.
7. Orteu C. The role of apoptosis in the resolution of T cell-mediated coetaneous inflammation. J Immunol 1998;161:1619-29.
8. Cezmi A. T cells and T cell-derived cytokines as pathogenic factors in the no allergic form atopic dermatitis. J Invest Dermatol 1999;113:628-34.
9. Akdis M. Skin-homing CD8 T cells respond to superantigen and contribute to eosinophilia and IgE production in atopic dermatitis. J Immunol 1999;163:466-75.
10. Scaffidi C. Two CD95 (APO-1/Fas) signaling pathways. EMBO J 1998;17:1675-87.
11. Lynch D. Fas and Fas ligand in the homeostatic regulation of immune responses. Immunology Today 1995;16:569-72.
12. Griffitch T. Fas ligand-induced apoptosis as a mechanism of immune privileged sites. Science 1995;270:1189-91.
13. Akbar A. Cellular environments and apoptosis: tissue microenvironments control active T cell death. Immunology Today 1997;99:439-46.
14. Ashkenazi A. Death receptors: Signaling and modulation. Science 1998;281:1305-8.
15. Pilling D. Interferon-beta mediates stromall cell rescue of T cells from apoptosis. Eur J Immunol 1999;29:1041-50.
16. Ohta K. Apoptosis of eosinophils and lymphocytes in allergic inflammation. J Allergy Clin Immunol 1999;104(1):564-70.
17. Trautmann A. T cell mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest 2000;106(1):25-35.
18. Bettina W. Delayed eosinophil programmed cell death: A common feature of inhalant allergy and extrinsic and intrinsic atopic dermatitis. J Allergy Clin Immunol 1997;100(4):233-40.
19. Kirckpatrick C. Transfer factor. J Allergy Clin Immunol 1993;81(5):803-13.
20. Estrada P. El factor de transferencia como agente terapéutico. Temas de inmunofarmacologia: Los estimulantes. 1993:19-37.
21. Navarro C. Factor de transferencia en dermatitis atópica moderada y severa. Revista Alergia México 1996;43(5):116-23.
22. Cordero M. Seguridad y eficacia en el tratamiento de la dermatitis atópica severa con ciclosporina A y factor de transferencia. Revista Alergia México 1999;46(2):49-60.
23. Sosa V. Tratamiento comparativo entre talidomida y factor de transferencia en dermatitis atopica severa. Revista Alergia México 2001;51(1):45-53.
24. Cezmi A. Immune regulation in atopic dermatitis. Curr Op Immunol 2000;12:641-6.
25. Grewe M. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunology Today 1998;161:415-20.
26. Simon H. Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia. Immunology Today 1995;16:53-55.
27. European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: The SCORAD Index. Dermatology 1993:186(1):23-31.
28. Vermes I. A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled annexin. J Immunol Methods 1995;184:39-51.
29. Nicoletti I. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991;139:271-9.